Results 1 to 10 of about 92,046 (305)
Comparison Between Urothelial and Non-Urothelial Urethral Cancer [PDF]
Frontiers in Oncology, 2021 BackgroundTo test the effect of variant histology relative to urothelial histology on stage at presentation, cancer specific mortality (CSM), and overall mortality (OM) after chemotherapy use, in urethral cancer.Materials and MethodsWithin the ...
Mike Wenzel +20 more
doaj +6 more sources
Non-urothelial and urothelial variants of bladder cancer
Cancer Treatment and Research Communications, 2022 Non-urothelial bladder cancers make up a rare minority of all genitourinary (GU) tract histologic cancers since urothelial cancer (UC) makes up the most common histologic subtype.
Eun-mi Yu +3 more
doaj +3 more sources
Phases of tight junction barrier disruption during transurothelial migration of invasive urothelial cancer cells [PDF]
Scientific ReportsBladder cancer is characterised by its multifocal nature and a high recurrence, yet the underlying mechanisms of these phenomena remain only partially understood. In the present study, we aimed to investigate transurothelial invasion of urothelial cancer
Tadeja Kuret +5 more
doaj +2 more sources
Diagnostics, 2021 In bladder cancer, urothelial carcinoma is the most common histologic subtype, accounting for more than 90% of cases. Pathogenic effects due to the dysbiosis of gut microbiota are localized not only in the colon, but also in regulating bladder cancer ...
Yen-Chieh Wang +6 more
doaj +1 more source
Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-β-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells. [PDF]
PLoS ONE, 2015 Cholesterol content can vary distinctly between normal and cancer cells, with elevated levels in cancer cells. Here, we investigated cholesterol sequestration with methyl-β-cyclodextrin (MCD), and pore-formation with the ostreolysin A/pleurotolysin B ...
Nataša Resnik +6 more
doaj +1 more source
Urothelial Cancer Stem Cells [PDF]
The Scientific World JOURNAL, 2010 There is mounting evidence supporting the idea that tumors, similar to normal adult tissues, arise from a specific stem-like cell population, the cancer stem cells (CSCs), which are considered as the real driving force behind tumor growth, the ability to metastasize, as well as resistance to conventional antitumor therapy.
Irena Dimov +2 more
openaire +4 more sources
Bladder and upper urinary tract cancers as first and second primary cancers
Cancer Reports, 2021 Background Previous population‐based studies on second primary cancers (SPCs) in urothelial cancers have focused on known risk factors in bladder cancer patients without data on other urothelial sites of the renal pelvis or ureter.
Guoqiao Zheng +5 more
doaj +1 more source
Enfortumab Vedotin in urothelial cancer [PDF]
Therapeutic Advances in Urology, 2020 The treatment landscape for metastatic urothelial cancer (mUC) beyond first-line platinum-based chemotherapy has changed significantly over the last 5 years with the recent approvals of the immune checkpoint inhibitors (ICIs), fibroblast growth factor receptor (FGFR) inhibitors and most recently Enfortumab Vedotin (EV).
Marie Alt +4 more
openaire +3 more sources
Frontiers in Oncology, 2021 Urothelial carcinoma therapy is a rapidly evolving and expanding field. Traditional cytotoxic chemotherapy regimens have not produced optimal long-term outcomes, and many urothelial cancer patients have comorbidities that disqualify them as chemotherapy ...
Blessie Elizabeth Nelson +2 more
doaj +1 more source
Mincle, an Innate Immune Receptor, Is Expressed in Urothelial Cancer Cells of Papillomavirus-Associated Urothelial Tumors of Cattle. [PDF]
PLoS ONE, 2015 Mincle, macrophage-inducible C-type lectin, is a member of C-type lectin receptors. It plays an important role in anti-mycobacterial and anti-fungal immunity.
Sante Roperto +7 more
doaj +1 more source